MAPK8 and Stroke: A study that combined overexpression of Ngb and an inhibitor of the c-jun N-terminal kinase (JNK), carried out in male spontaneously hypertensive prone stroke rats, reported that this treatment reduced the infarct size, and improved the neurologic outcome 14 days after transient MCAO (tMCAO) [62].